Tuesday, 18 February 2020

Japan News

  • Takeda to acquire Envoy Therapeutics

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2012

    Singapore: Takeda Pharmaceutical's wholly-owned subsidiary, Takeda America, and Envoy Therapeutics have entered into a definitive agreement for Takeda America to acquire Envoy. Takeda exp...Read more

  • Takeda drug gets positive CHMP opinion

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2012

    Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for conditional approval of brentuximab vedotin by ...Read more

  • Abbott, Eisai receive approval to market Humira

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Aug, 2012

    Singapore: Abbott Japan and Eisai have received approval from Japan's Ministry of Health, Labor and Welfare to market Humira Pre-filled Syringe 40 mg/0.8 mL for subcutaneous injection (adal...Read more

  • Daiichi develops antibody to prevent fracture

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 16 Oct, 2012

    Singapore: Daiichi Sankyo's 24-month randomized, double-blind, placebo-controlled multi-center phase III clinical trial with AMG 162 (denosumab) (Denosumab fracture Intervention Randomized ...Read more

  • Japan approves NDA for hyperlipidemia drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2012

    Singapore: The Japanese Ministry of Health, Labor and Welfare has approved a new drug application (NDA) of Lotriga granular capsule 2g (omega-3-acid ethyl esters 90) for the treatment of hy...Read more

  • Shionogi-ViiV Healthcare announces trial results of dolutegravir

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2012

    Singapore: Initial results received from the phase III SINGLE (ING114467) study of Shionogi-ViiV Healthcare's investigational integrase inhibitor dolutegravir in treatment-naive adults with...Read more

  • What is the revenue size, range of CROs in APAC?

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • FIPB clears seven pharma proposals, defers three

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

    Singapore: The Foreign Investment Promotion Board (FIPB) has cleared seven out of the ten investment proposals in the pharmaceutical and biotechnology sector. At the board meeting held on F...Read more

  • Kyoto University gets patents for iPS cell technology

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Oct, 2012

    Singapore: Kyoto University has been granted four patents relating to its basic iPS cell technology, one in Japan and three in the US. Two of the US patents have already completed patent re...Read more

  • Japanese MMA for Mitsubishi's diabetes drug

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2014

    Singapore: Mitsubishi Tanabe Pharma and Daiichi Sankyo have announced that Mitsubishi Tanabe Pharma has received approval to manufacture and market the SGLT2 inhibitor, Canaglu tablets (can...Read more

  • Astellas seeks to market enzalutamide in Europe

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 27 Jun, 2012

    Singapore: Japan-based Astellas Pharma has submitted a European marketing authorization application to the European Medicines Agency (EMA) for enzalutamide for the treatment of men with met...Read more

  • Daiichi seeks approval of Topotecin use in children

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 09 Nov, 2012

    Singapore: Daiichi Sankyo has submitted a supplemental new drug application to Japan's Ministry of Health, Labor and Welfare for an additional indication for Topotecin 40 mg and 100 mg (iri...Read more

  • Astellas invests $140 mn on expansion in the US

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jun, 2012

    Singapore: Tokyo-based Astellas, a pharmaceutical company, is investing $140 million to locate its headquarters for the Americas in Glenview, Illinois, US. The investment and the expansion ...Read more

  • Google, Facebook, Apple launch 'Breakthrough Prize in Life Sciences'

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 Feb, 2013

    Singapore: Mr Sergey Brin (computer scientist and co-founder of Google), Ms Anne Wojcicki (American biologist, co-founder of 23andMe, and wife of Mr Brin), Mr Mark Zuckerberg (co-founder o...Read more

  • New R&D center to advance rice research in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2013

    Singapore: The agriculture ministry of Japan will set up a center to develop rice strains, using genetic studies, that are flavorful but disease-resistant varieties, to meet local needs. Th...Read more

  • Daiichi, Ranbaxy promote generics in Brazil

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 18 Apr, 2013

    New Delhi: Daiichi Sankyo and Ranbaxy will work in synergy in Brazil to expand the business of both companies in the country. As part of this synergy, Ranbaxy will support Daiichi Sankyo's ...Read more

  • Japan medtech firm signs $9 mn deal with A*Star

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 27 May, 2013

    Singapore: Japan's technology company, Arkray is investing $9.1 million over a five-year period in a research venture and collaboration with A*Star's Institute of Bioengineering and Nanotec...Read more

  • Fujifilm opens new lens factory in Philippines

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

    Singapore: Fujifilm Corporation has started full-scale operation of Fujifilm Optics Philippines in Laguna. The new company will become the core production base for high-performance lenses u...Read more